New York, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Medical Foods Industry" - https://www.reportlinker.com/p06032153/?utm_source=GNW
1% over the period 2020-2027. Oral, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$16.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Enteral segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $5.1 Billion, While China is Forecast to Grow at 7.9% CAGR
- The Medical Foods market in the U.S. is estimated at US$5.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2027 trailing a CAGR of 7.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.
- Select Competitors (Total 40 Featured) -
- Abbott
- Danone
- Fresenius Kabi AG
- Mead Johnson & Company, LLC
- Nestlé
- Primus Pharmaceuticals, Inc.
- Targeted Medical Pharma, Inc.
Read the full report: https://www.reportlinker.com/p06032153/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Medical Foods by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 2: World Historic Review for Medical Foods by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 3: World 15-Year Perspective for Medical Foods by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Oral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR
Table 5: World Historic Review for Oral by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Oral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Enteral by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Enteral by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Enteral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Pathogen-Related
Infections by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Pathogen-Related Infections
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Pathogen-Related
Infections by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 13: World Current & Future Analysis for Attention Deficit
Hyperactivity Disorder by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Attention Deficit
Hyperactivity Disorder by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Attention Deficit
Hyperactivity Disorder by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 16: World Current & Future Analysis for Alzheimer`s
Disease by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Alzheimer`s Disease by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Alzheimer`s Disease by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Diabetic
Neuropathy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Diabetic Neuropathy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Diabetic Neuropathy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 25: World Current & Future Analysis for Chronic Kidney
Disease by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 26: World Historic Review for Chronic Kidney Disease by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Chronic Kidney Disease
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Minimal Hepatic
Encephalopathy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR
Table 29: World Historic Review for Minimal Hepatic
Encephalopathy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Minimal Hepatic
Encephalopathy by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 31: World Current & Future Analysis for
Chemotherapy-Induced Diarrhea by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 32: World Historic Review for Chemotherapy-Induced
Diarrhea by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 33: World 15-Year Perspective for Chemotherapy-Induced
Diarrhea by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 34: World Current & Future Analysis for Institutional by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 35: World Historic Review for Institutional by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 36: World 15-Year Perspective for Institutional by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 37: World Current & Future Analysis for Retail by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 38: World Historic Review for Retail by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 39: World 15-Year Perspective for Retail by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 40: World Current & Future Analysis for Online by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 41: World Historic Review for Online by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 42: World 15-Year Perspective for Online by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 43: USA Current & Future Analysis for Medical Foods by
Route Of Administration - Oral and Enteral - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 44: USA Historic Review for Medical Foods by Route Of
Administration - Oral and Enteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 45: USA 15-Year Perspective for Medical Foods by Route Of
Administration - Percentage Breakdown of Value Sales for Oral
and Enteral for the Years 2012, 2020 & 2027
Table 46: USA Current & Future Analysis for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 47: USA Historic Review for Medical Foods by Application -
Pathogen-Related Infections, Attention Deficit Hyperactivity
Disorder, Alzheimer`s Disease, Other Applications, Diabetic
Neuropathy, Chronic Kidney Disease, Minimal Hepatic
Encephalopathy and Chemotherapy-Induced Diarrhea Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 48: USA 15-Year Perspective for Medical Foods by
Application - Percentage Breakdown of Value Sales for
Pathogen-Related Infections, Attention Deficit Hyperactivity
Disorder, Alzheimer`s Disease, Other Applications, Diabetic
Neuropathy, Chronic Kidney Disease, Minimal Hepatic
Encephalopathy and Chemotherapy-Induced Diarrhea for the Years
2012, 2020 & 2027
Table 49: USA Current & Future Analysis for Medical Foods by
Distribution Channel - Institutional, Retail and Online -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 50: USA Historic Review for Medical Foods by Distribution
Channel - Institutional, Retail and Online Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 51: USA 15-Year Perspective for Medical Foods by
Distribution Channel - Percentage Breakdown of Value Sales for
Institutional, Retail and Online for the Years 2012, 2020 &
2027
CANADA
Table 52: Canada Current & Future Analysis for Medical Foods by
Route Of Administration - Oral and Enteral - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 53: Canada Historic Review for Medical Foods by Route Of
Administration - Oral and Enteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 54: Canada 15-Year Perspective for Medical Foods by Route
Of Administration - Percentage Breakdown of Value Sales for
Oral and Enteral for the Years 2012, 2020 & 2027
Table 55: Canada Current & Future Analysis for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 56: Canada Historic Review for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 57: Canada 15-Year Perspective for Medical Foods by
Application - Percentage Breakdown of Value Sales for
Pathogen-Related Infections, Attention Deficit Hyperactivity
Disorder, Alzheimer`s Disease, Other Applications, Diabetic
Neuropathy, Chronic Kidney Disease, Minimal Hepatic
Encephalopathy and Chemotherapy-Induced Diarrhea for the Years
2012, 2020 & 2027
Table 58: Canada Current & Future Analysis for Medical Foods by
Distribution Channel - Institutional, Retail and Online -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 59: Canada Historic Review for Medical Foods by
Distribution Channel - Institutional, Retail and Online Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 60: Canada 15-Year Perspective for Medical Foods by
Distribution Channel - Percentage Breakdown of Value Sales for
Institutional, Retail and Online for the Years 2012, 2020 &
2027
JAPAN
Table 61: Japan Current & Future Analysis for Medical Foods by
Route Of Administration - Oral and Enteral - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 62: Japan Historic Review for Medical Foods by Route Of
Administration - Oral and Enteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 63: Japan 15-Year Perspective for Medical Foods by Route
Of Administration - Percentage Breakdown of Value Sales for
Oral and Enteral for the Years 2012, 2020 & 2027
Table 64: Japan Current & Future Analysis for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 65: Japan Historic Review for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 66: Japan 15-Year Perspective for Medical Foods by
Application - Percentage Breakdown of Value Sales for
Pathogen-Related Infections, Attention Deficit Hyperactivity
Disorder, Alzheimer`s Disease, Other Applications, Diabetic
Neuropathy, Chronic Kidney Disease, Minimal Hepatic
Encephalopathy and Chemotherapy-Induced Diarrhea for the Years
2012, 2020 & 2027
Table 67: Japan Current & Future Analysis for Medical Foods by
Distribution Channel - Institutional, Retail and Online -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 68: Japan Historic Review for Medical Foods by
Distribution Channel - Institutional, Retail and Online Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 69: Japan 15-Year Perspective for Medical Foods by
Distribution Channel - Percentage Breakdown of Value Sales for
Institutional, Retail and Online for the Years 2012, 2020 &
2027
CHINA
Table 70: China Current & Future Analysis for Medical Foods by
Route Of Administration - Oral and Enteral - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 71: China Historic Review for Medical Foods by Route Of
Administration - Oral and Enteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 72: China 15-Year Perspective for Medical Foods by Route
Of Administration - Percentage Breakdown of Value Sales for
Oral and Enteral for the Years 2012, 2020 & 2027
Table 73: China Current & Future Analysis for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 74: China Historic Review for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 75: China 15-Year Perspective for Medical Foods by
Application - Percentage Breakdown of Value Sales for
Pathogen-Related Infections, Attention Deficit Hyperactivity
Disorder, Alzheimer`s Disease, Other Applications, Diabetic
Neuropathy, Chronic Kidney Disease, Minimal Hepatic
Encephalopathy and Chemotherapy-Induced Diarrhea for the Years
2012, 2020 & 2027
Table 76: China Current & Future Analysis for Medical Foods by
Distribution Channel - Institutional, Retail and Online -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 77: China Historic Review for Medical Foods by
Distribution Channel - Institutional, Retail and Online Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 78: China 15-Year Perspective for Medical Foods by
Distribution Channel - Percentage Breakdown of Value Sales for
Institutional, Retail and Online for the Years 2012, 2020 &
2027
EUROPE
Table 79: Europe Current & Future Analysis for Medical Foods by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 80: Europe Historic Review for Medical Foods by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 81: Europe 15-Year Perspective for Medical Foods by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027
Table 82: Europe Current & Future Analysis for Medical Foods by
Route Of Administration - Oral and Enteral - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 83: Europe Historic Review for Medical Foods by Route Of
Administration - Oral and Enteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 84: Europe 15-Year Perspective for Medical Foods by Route
Of Administration - Percentage Breakdown of Value Sales for
Oral and Enteral for the Years 2012, 2020 & 2027
Table 85: Europe Current & Future Analysis for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 86: Europe Historic Review for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 87: Europe 15-Year Perspective for Medical Foods by
Application - Percentage Breakdown of Value Sales for
Pathogen-Related Infections, Attention Deficit Hyperactivity
Disorder, Alzheimer`s Disease, Other Applications, Diabetic
Neuropathy, Chronic Kidney Disease, Minimal Hepatic
Encephalopathy and Chemotherapy-Induced Diarrhea for the Years
2012, 2020 & 2027
Table 88: Europe Current & Future Analysis for Medical Foods by
Distribution Channel - Institutional, Retail and Online -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 89: Europe Historic Review for Medical Foods by
Distribution Channel - Institutional, Retail and Online Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 90: Europe 15-Year Perspective for Medical Foods by
Distribution Channel - Percentage Breakdown of Value Sales for
Institutional, Retail and Online for the Years 2012, 2020 &
2027
FRANCE
Table 91: France Current & Future Analysis for Medical Foods by
Route Of Administration - Oral and Enteral - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 92: France Historic Review for Medical Foods by Route Of
Administration - Oral and Enteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 93: France 15-Year Perspective for Medical Foods by Route
Of Administration - Percentage Breakdown of Value Sales for
Oral and Enteral for the Years 2012, 2020 & 2027
Table 94: France Current & Future Analysis for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 95: France Historic Review for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 96: France 15-Year Perspective for Medical Foods by
Application - Percentage Breakdown of Value Sales for
Pathogen-Related Infections, Attention Deficit Hyperactivity
Disorder, Alzheimer`s Disease, Other Applications, Diabetic
Neuropathy, Chronic Kidney Disease, Minimal Hepatic
Encephalopathy and Chemotherapy-Induced Diarrhea for the Years
2012, 2020 & 2027
Table 97: France Current & Future Analysis for Medical Foods by
Distribution Channel - Institutional, Retail and Online -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 98: France Historic Review for Medical Foods by
Distribution Channel - Institutional, Retail and Online Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 99: France 15-Year Perspective for Medical Foods by
Distribution Channel - Percentage Breakdown of Value Sales for
Institutional, Retail and Online for the Years 2012, 2020 &
2027
GERMANY
Table 100: Germany Current & Future Analysis for Medical Foods
by Route Of Administration - Oral and Enteral - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 101: Germany Historic Review for Medical Foods by Route
Of Administration - Oral and Enteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 102: Germany 15-Year Perspective for Medical Foods by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Enteral for the Years 2012, 2020 & 2027
Table 103: Germany Current & Future Analysis for Medical Foods
by Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 104: Germany Historic Review for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 105: Germany 15-Year Perspective for Medical Foods by
Application - Percentage Breakdown of Value Sales for
Pathogen-Related Infections, Attention Deficit Hyperactivity
Disorder, Alzheimer`s Disease, Other Applications, Diabetic
Neuropathy, Chronic Kidney Disease, Minimal Hepatic
Encephalopathy and Chemotherapy-Induced Diarrhea for the Years
2012, 2020 & 2027
Table 106: Germany Current & Future Analysis for Medical Foods
by Distribution Channel - Institutional, Retail and Online -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 107: Germany Historic Review for Medical Foods by
Distribution Channel - Institutional, Retail and Online Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 108: Germany 15-Year Perspective for Medical Foods by
Distribution Channel - Percentage Breakdown of Value Sales for
Institutional, Retail and Online for the Years 2012, 2020 &
2027
ITALY
Table 109: Italy Current & Future Analysis for Medical Foods by
Route Of Administration - Oral and Enteral - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 110: Italy Historic Review for Medical Foods by Route Of
Administration - Oral and Enteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 111: Italy 15-Year Perspective for Medical Foods by Route
Of Administration - Percentage Breakdown of Value Sales for
Oral and Enteral for the Years 2012, 2020 & 2027
Table 112: Italy Current & Future Analysis for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 113: Italy Historic Review for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Minimal Hepatic Encephalopathy and Chemotherapy-Induced
Diarrhea Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 114: Italy 15-Year Perspective for Medical Foods by
Application - Percentage Breakdown of Value Sales for
Pathogen-Related Infections, Attention Deficit Hyperactivity
Disorder, Alzheimer`s Disease, Other Applications, Diabetic
Neuropathy, Chronic Kidney Disease, Minimal Hepatic
Encephalopathy and Chemotherapy-Induced Diarrhea for the Years
2012, 2020 & 2027
Table 115: Italy Current & Future Analysis for Medical Foods by
Distribution Channel - Institutional, Retail and Online -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 116: Italy Historic Review for Medical Foods by
Distribution Channel - Institutional, Retail and Online Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 117: Italy 15-Year Perspective for Medical Foods by
Distribution Channel - Percentage Breakdown of Value Sales for
Institutional, Retail and Online for the Years 2012, 2020 &
2027
UNITED KINGDOM
Table 118: UK Current & Future Analysis for Medical Foods by
Route Of Administration - Oral and Enteral - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 119: UK Historic Review for Medical Foods by Route Of
Administration - Oral and Enteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 120: UK 15-Year Perspective for Medical Foods by Route Of
Administration - Percentage Breakdown of Value Sales for Oral
and Enteral for the Years 2012, 2020 & 2027
Table 121: UK Current & Future Analysis for Medical Foods by
Application - Pathogen-Related Infections, Attention Deficit
Hyperactivity Disorder, Alzheimer`s Disease, Other
Applications, Diabetic Neuropathy, Chronic Kidney Disease,
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032153/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
